MONTREAL, May 9 /PRNewswire-FirstCall/ - CryoCath , will hold a conference call to discuss its second quarter 2007 financial results at 4:30 p.m. (Eastern Time) on May 15, 2007. The Company will report its results in a press release to be issued at 4:00 p.m. prior to the call.
DATE: Tuesday, May 15, 2007 TIME: 4:30 p.m., Eastern Standard Time TAPED REPLAY: 416-640-1917 or 1-877-289-8525 (Available until February 20, 2007) REFERENCE NUMBER: 21231087 WEBCAST: A live audio webcast of the call will be available at www.cryocath.com. Webcast attendees are welcome to listen to the conference in real-time or on-demand at their convenience. The webcast will be archived for 365 days. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. About CryoCath
CryoCath - www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter and surgical products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.
This press release includes “forward-looking statements” that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath’s annual report available at www.sedar.com under the heading Risks and Uncertainties in the Management’s Discussion and Analysis section.
CryoCath Technologies Inc.
CONTACT: For further information visit our website at www.cryocath.com, orcontact: Michael Moore, Investor Relations, Phone: (416) 815-0700 ext. 241,Fax: (416) 815-0080, E-mail: mmoore@equicomgroup.com
